Executive Summary

Prices are negotiated and established for both public and private sector by the CMED during the marketing authorisation process. The detailed price setting procedure depend on the products characteristics (e.g. new drug, me-too, new presentation of already marketed drug). Product prices are revised annually to adjust for inflation rate, exchange rate and degree of generic market penetration.